Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 3/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.30 |
| ▸ | KDR | P35968 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL577735 | 0.88 | LMNA (0.42) | LMNAHCAR2TSHRALDH1A1ESR1 | |
| SCHEMBL5012808 | 0.86 | FAAH (0.39) | FAAHLMNACHRNB2CHRNA4CHRNB4 | |
| SCHEMBL4921566 | 0.83 | FAAH (0.47) | FAAHLMNATSHRCNR1CNR2 | |
| SCHEMBL4439901 | 0.80 | HCAR2 (0.36) | FAAHLMNAHCAR2TSHRALDH1A1 | |
| SCHEMBL2984925 | 0.80 | HCAR2 (0.36) | FAAHLMNAHCAR2TSHRALDH1A1 | |
| SCHEMBL2982786 | 0.80 | HCAR2 (0.36) | FAAHLMNAHCAR2TSHRALDH1A1 | |
| SCHEMBL18856280 | 0.80 | FAAH (0.57) | FAAHLMNACNR1CNR2ALDH1A1 | |
| SCHEMBL12120695 | 0.78 | LMNA (0.41) | FAAHLMNAHCAR2TSHRCNR1 | |
| SCHEMBL12712171 | 0.78 | CA1 (0.43) | LMNACHRNB2CHRNA4CHRNB4CHRNA3 | |
| Tert-Butyl Hydroperoxide SCHEMBL27806184 | 0.78 | LMNA (0.35) | LMNAHCAR2TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030069204-A1 | Strain of streptomyces | SANKYO COMPANY LIMITED (JP) | 2003-04-10 | — | — | US | disclosed |
| EP-0497978-A1 | CEPHALOSPORIN COMPOUNDS AND PRODUCTION THEREOF | Kyoto Pharmaceutical Industries, Ltd. (JP) | 1992-08-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069204-A1 | Strain of streptomyces | O60361, CYP8B1, MRPS34 | FAAH 357/4885LMNA 3952/4885CHRNB2 4645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.